GSA Capital Partners’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,457
Closed -$330K 1890
2024
Q3
$330K Buy
+14,457
New +$327K 0.02% 1177
2022
Q2
Sell
-20,357
Closed -$807K 1677
2022
Q1
$807K Buy
20,357
+5,002
+33% +$196K 0.11% 270
2021
Q4
$638K Buy
+15,355
New +$668K 0.08% 446
2020
Q2
Sell
-6,038
Closed -$275K 949
2020
Q1
$275K Buy
+6,038
New +$363K 0.07% 541

Other funds holding NRC

GSA Capital Partners's NRC Position: Q4 2024 in Review

GSA Capital Partners sold out of NRC Health Common Stock (NRC) in Q4 2024, closing a stake of 14,457 shares — an estimated $330K sold.

GSA Capital Partners first reported a position in NRC in Q1 2020 and held it in 4 quarters. The position peaked at $807K in Q1 2022. 133 funds tracked by Wall St. Rank hold NRC as of Q4 2024.

  • GSA Capital Partners reported no remaining NRC Health Common Stock position as of Q4 2024 after selling out during the quarter.
  • GSA Capital Partners sold 14,457 NRC Health Common Stock shares in Q4 2024, an estimated $330K.
  • GSA Capital Partners first reported a position in NRC Health Common Stock in Q1 2020 and held it in 4 quarters.
  • GSA Capital Partners's NRC Health Common Stock position peaked at $807K in Q1 2022.
  • 133 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2024.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.